The unifying hypothesis to be tested in this proposal is that the compartmentalized regulation mediated by Guanylate Cyclase-C (GC-C), Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Multiple Drug-associated Protein-4 (MRP4) macromolecular complexes at or near the plasma membrane of gut epithelial cells regulates cGMP mediated secretory diarrhea. We will test this hypothesis using transgenic mice model (in vivo studies) and patient derived intestinal stem cells derived from crypts (enteroids) to study fluid secretion in vitro. The proposed studies are highly significant because (i) it addresses the pathologies of several deadly human diseases by utilizing models from humans and mice; (ii) it has clinical relevance and implications; (iii) it is a multidisciplinary project covers basic biomedical studies, assay developments, and uses personalized human stem cell cultures.

Public Health Relevance

In this grant proposal, we will address a novel mechanism of how protein-protein interactions can contribute to the progression of Travelers diarrhea (TD). We hypothesize that compartmentalized regulation mediated by Guanylate Cyclase-C (GC-C), Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Multiple Drug-associated Protein-4 (MRP4) macromolecular complexes at or near the plasma membrane of gut epithelial cells regulates cGMP (cyclic guanosine monophosphate) mediated secretory diarrhea. By targeting this macromolecular complex, we may find ways to control fluid secretion and thereby control or cure the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK080834-13
Application #
9933890
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Shea-Donohue, Terez
Project Start
2009-08-20
Project End
2023-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Thomas, Andrew; Ramananda, Yashaswini; Mun, KyuShik et al. (2018) AC6 is the major adenylate cyclase forming a diarrheagenic protein complex with cystic fibrosis transmembrane conductance regulator in cholera. J Biol Chem 293:12949-12959
Zhang, Weiqiang; Zhang, Zhihong; Zhang, Yanhui et al. (2017) CFTR-NHERF2-LPA? Complex in the Airway and Gut Epithelia. Int J Mol Sci 18:
Arora, Kavisha; Huang, Yunjie; Mun, Kyushik et al. (2017) Guanylate cyclase 2C agonism corrects CFTR mutants. JCI Insight 2:
Arora, Kavisha; Yarlagadda, Sunitha; Zhang, Weiqiang et al. (2016) Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation. Am J Physiol Lung Cell Mol Physiol 311:L364-74
Sinha, Chandrima; Arora, Kavisha; Naren, Anjaparavanda P (2016) Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration. J Vis Exp :53973
Zhang, W; Zhang, X; Zhang, Y H et al. (2016) Lumacaftor/ivacaftor combination for cystic fibrosis patients homozygous for Phe508del-CFTR. Drugs Today (Barc) 52:229-37
Giridhar, Premkumar Vummidi; Bell, Sheila M; Sridharan, Anusha et al. (2016) Airway Epithelial KIF3A Regulates Th2 Responses to Aeroallergens. J Immunol 197:4228-4239
Kimura, Yasuhiro; van der Merwe, Marie; Bering, Stine B et al. (2015) Glucose transport by epithelia prepared from harvested enterocytes. Cytotechnology 67:39-49
Balogh, Andrea; Shimizu, Yoshibumi; Lee, Sue Chin et al. (2015) The autotaxin-LPA2 GPCR axis is modulated by ?-irradiation and facilitates DNA damage repair. Cell Signal 27:1751-62
Hildebrandt, Ellen; Mulky, Alok; Ding, Haitao et al. (2015) A stable human-cell system overexpressing cystic fibrosis transmembrane conductance regulator recombinant protein at the cell surface. Mol Biotechnol 57:391-405

Showing the most recent 10 out of 38 publications